Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 100 for transplant

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Repository of Atria Tissue for the Investigation of Atrial Pathophysiology in Patients with Atrial Fibrillation

    Rochester, MN

  3. A Study to Evaluate Pulmonary Vascular Complications of Liver Disease 3 (PVCLD3)

    Rochester, MN

  4. Ultrasound Microvessel Imaging of Transplant Kidney

    Rochester, MN

  5. A Study to Assess Reproductive History in Kidney Donors

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of Sulfonamide Allergy

    Rochester, MN

  7. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration

    Eau Claire, WI, Rochester, MN, Scottsdale/Phoenix, AZ

  8. Symptoms, Sleep Characteristics, and Disability in Solid Organ Transplant Recipients

    Scottsdale/Phoenix, AZ

  9. Liver Transplant Candidates Sleep Related Breathing Disorders

    Rochester, MN

  10. A Study to Develop a Breath Analysis Test

    Jacksonville, FL

.

Mayo Clinic Footer